• 154,079+ Medical Conferences
  • 285 Specialties
  • 11,284 Organizers
  • 156,282 Speakers
  • 159 Countries
  • 4,783 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Fred R. Hirsch
Fred R. Hirsch

Fred R. Hirsch

    MD, PhD
Professor, Chief Executive Officer | Aurora, Colorado    United States of America
Oncology, Pathology
Pathology, Lung Cancer,...More
Spoken at 6 events

Biography :

Dr. Hirsch is a Professor of Medicine and Pathology at the University of Colorado School of Medicine in Aurora, Colorado, USA. His research interests include translational research, biomarkers and targeted therapies, and early detection of lung cancer. Dr. Hirsch’s research has helped identify and validate prognostic markers for lung cancer outcomes and predictive markers for personalized lung cancer therapies.

Dr. Hirsch is the principle investigator on an NCI SPECS grant to establish biomarkers for squamous cell lung cancer and chairs the translational research component of the SWOG lung cancer committee. He holds a medical degree and doctorate from the University of Copenhagen and a degree from the Copenhagen Business School. His specialty is medical oncology, but trained in pathology as well.

Dr. Hirsch has been an active member of the IASLC since 1977. He has served as Chair of the Pathology Committee, Chair of the Prevention and Early Detection Committee and is Associate Editor for the IASLC Journal: Journal of Thoracic Oncology. He has served on the Board of Directors for IASLC since 2005, and he currently serves as the Treasurer of IASLC. He was the editor of the IASLC newsletter from 2000-2013 when his term ended. He received the Mary J. Matthews Award in 2007 for life-time achievements in pathology and translational research of thoracic malignancies. He is the Congress President for the 16th World Conference on Lung Cancer to be held in Denver, CO, USA in 2015.

** ************
For speaker's contact information - Contact us


Oncology, Pathology

Interested Topics

Pathology, Lung cancer, Translational research, Biomarkers, Targeted therapies, Prevention, Thoracic Oncology, Medical Oncology, Clinical Research

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials


Send Message